Answers are grounded in this paper and cite their sources.
Aldose reductase (ALR2) is a critical enzyme in the development of the major complications of diabetes mellitus. Herein, new molecular entities active against ALR2 were discovered through an integrated receptor- and ligand-based virtual screening campaign. Twelve candidates were found to inhibit this enzyme in the micromolar range including two ligands having an IC(50) below 3 muM. Six new compounds, structurally unrelated to the known ARIs, have been identified, opening up opportunity for lead optimization.
No takes yet. Share an insight, caveat, or question.
Cosconati et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: